We're looking forward to attending Goldman Sachs 45th Annual Global Healthcare Conference on June 12th. Join us for a fireside chat at 2:00 pm ET here: bit.ly/4cbtTpJ

This morning, we provided an update on our #HuntingtonsDisease program. Read the latest news here: bit.ly/4egp7ZQ

We are proud to share that Matt Lasmanis, Sage's Chief Technology and Innovation Officer, has been named to Constellation Research's #BT150 list! Learn more: bit.ly/4b3B5Dc

Update: We will present second quarter financial results on Wednesday, July 31st, 2024 at 4:30 pm ET via live webcast and conference call. Learn more: bit.ly/4bKN0WR $SAGE

With our partner, @Biogen, today we announced topline results from the KINETIC 2 Study in Essential Tremor. Read more: investor.sagerx.com/news-releases/…

Join us today at 4:30 pm ET for our second quarter financial results via conference call and webcast: bit.ly/3zUp0Dv $SAGE

This weekend, the Sage team will be attending EHDN News & Enroll-HD 2024 in France. We look forward to sharing our #HuntingtonsDisease (HD) research, including an overview of our HD clinical studies. #EHDN2024

We are incredibly honored to share that Sage Therapeutics, in collaboration with our partners at Biogen, has been named a winner for PM360's prestigious Trailblazer Award in the “Product Launch of the Year” category for our work in #PostpartumDepression.

Today, we announced topline results from our Phase 2 LIGHTWAVE study in the treatment of mild cognitive impairment in Alzheimer’s disease. Read more: bit.ly/3XV7ebK

Update: We will present third quarter financial results on October 29th, 2024 at 4:30 pm ET via live webcast and conference call. Learn more: bit.ly/48b7SXc $SAGE

The Sage team is excited to attend Psych Congress Network this week. We look forward to connecting with industry leaders dedicated to improving the diagnosis and treatment of maternal mental health and postpartum depression (PPD).​ ​ Learn more here: bit.ly/40oZAZI

Join us today at 4:30 pm ET for our third quarter financial results via conference call and webcast: bit.ly/40kceJv $SAGE

This week at Psych Congress Network, Sage Therapeutics, in partnership with NAMI and @Biogen, shared new insights into #postpartumdepression (PPD) and its impact on women and families. ​ We're proud to announce that our joint research poster focused on the burden of PPD has

On December 4th, join us for our fireside chat at the 2024 Piper Sandler Healthcare Conference. The #LIVE webcast begins streaming at 9:00 AM ET. Watch here: bit.ly/4i0cDan $SAGE

We look forward to our presentation at J.P. Morgan Healthcare Conference on January 15 at 8:15 AM PST. Join the live webcast and hear about the year ahead: bit.ly/4gDxPlI #JPM25

We will present financial results for the fourth quarter and full year of 2024 on Tuesday, February 11, 2025 at 4:30 PM ET via live webcast and conference call. Learn more: bit.ly/40z9RRG $SAGE

Join us today at 4:30 pm ET for our fourth quarter and full year 2024 financial results via conference call and webcast: bit.ly/4hVy1wX $SAGE

We support Maternal Mental Health Leadership Alliance (MMHLA)’s first-ever National #DayofAction for #MaternalMentalHealth. About 1 in 8 women report experiencing symptoms of #postpartumdepression, yet many lack support. Together, we can help drive lasting change by raising awareness and advocating for better care.

We will present financial results for the first quarter of 2025 on Tuesday, April 29, 2025 at 4:30 PM ET via live webcast and conference call. Learn more: bit.ly/3EoSJXI $SAGE

Join us today at 4:30 pm ET for our first quarter 2025 financial results via conference call and webcast: bit.ly/4jOaVsS $SAGE